Long-Term Infusion of Anti-GD2 Antibody CH14.18/CHO in Combination with Interleukin-2 (IL2) in a Multicenter Phase II Clinical Trial in Patients with High Risk Neuroblastoma
PEDIATRIC BLOOD & CANCER（2016）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要